Mandate

Vinge has assisted Cavotec SA in a directed new share issue

September 12, 2014

Vinge has asssited Cavotec SA in a directed new share issue to Bure Equity AB. The new issue consists of 7,138,780 new shares, corresponding to approx. 9.9% of the total number of shares outstanding in Cavotec, and will provide Cavotec with net proceeds of approx. SEK 187 million.

The Vinge team included Jesper Schönbeck and Joakim Hagberg.

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025